IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2663-2668

  Lee, Myung Shik ^a,c   Mueller, Regula ^a   Wicker, Linda S ^b   Peterson, Laurence B ^b   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; DIABETES MELLITUS; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HOMOZYGOSITY; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ALLELES; ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 1; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOMOZYGOTE; INTERLEUKIN-10; ISLETS OF LANGERHANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, INBRED STRAINS; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION;

EID: 0029896602     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2663     Document Type: Article

References (33)

1. Malefyt, R.D.W., J. Haanen, H. Spits, M.-G. Roncarolo, A.T. Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J.E. de Vris. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915-924.
2. Fiorentino, D.F., A. Zlotnik, P. Vieira, T.R. Mosmann, M. Howard, K.W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444-3451.
3. Ding, L., and E.M. Shevach. 1992. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148:3133-3139.
4. Ding, L., P.S. Linsley, L.-Y. Huang, R.N. Germain, and E.M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224-1234.
5. Lee, M.-S., L. Wogensen, J. Shizuru, M.B.A. Oldstone, and N. Sarvetnick. 1994. Pancreatic islet production of murine interleukin 10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 93:1332-1338.
6. Wogensen, L., M.-S. Lee, and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of b cells in nonobese diabetic mice. J. Exp. Med. 179:1379-1384.
7. Moritani, M., K. Yoshimoto, F. Tashiro, C. Hashimoto, J. Miyazaki, S. Ii, E. Kudo, H. Iwahana, Y. Hayashi, T. Sano, and M. Itakura. 1994. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6:1927-1936.
8. Wogensen, L., X. Huang, and N. Sarvetnick. 1993. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin-10 in the islets of Langerhans. J. Exp. Med. 178:175-185.
9. Ghosh, S., S.M. Palmer, N.R. Rodrigues, H.J. Cordell, C.M. Hearne, R.J. Cornall, J.-B. Prins, P. McShane, G.M. Lathrop, L.B. Peterson et al. 1993. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat. Genet. 4:404-409.
10. Pennline, K.J., E. Roque-Gaffney, and M. Monahan. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:169-175.
11. Wahl, S.M. 1994. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180:1587-1590.
12. Allison, J., P. McClive, L. Oxbrow, A. Baxter, G. Morahan, and J.F.A.P. Miller. 1994. Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet β-cells. Eur. J. Immunol. 24:2535-2541.
13. Katz, J.D., C. Benoist, and D. Mathis. 1995. T helper cell subset in insulin-dependent diabetes. Science (Wash. DC). 268:1185-1188.
14. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell. 80:707-718.
15. Lenschow, D.J., S.C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K.C. Herold, and J.A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145-1155.
16. Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, D.-H. Hsu, R. Kastelein, K.W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA. 89:1890-1893.
17. Defrance, T., B. Vanbervliet, F. Briere, I. Durand, F. Rousset, and J. Banchereau. 1992. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175:671-682.
18. Llorente, L., W. Zou, Y. Levy, Y. Richaud-Patin, J. Widjenes, J. Alcocer-Varela, B. Morel-Fourrier, J.-C. Brouet, D. Alarcon-Segovia, G. Pierre, and D. Emilie. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:839-844.
19. Fatenejad, S., M.J. Mamula, and J. Craft. 1993. Role of intermolecular/intrastructural B- and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc. Natl. Acad. Sci. USA. 90:12010-12014.
20. Mamula, M.J., S. Fataenejad, and J. Craft. 1994. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152:1453-1461.
21. Go, N.F., B.E. Castle, R. Barrett, R. Kastelein, W. Dang, T.R. Mosmann, K.W. Moore, and M. Howard. 1990. Interleukin-10, a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1625-1631.
22. Ishida, H., T. Muchamuel, S. Sakaguchi, S. Andrade, S. Menon, and M. Howard. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179:305-310.
23. Kaufman, D.L., M. Clare-Salzler, J. Tian, T. Forsthuber, G.S.P. Ting, P. Robinson, M.A. Atkinson, E.E. Sercarz, A.J. Tobin, and P.V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (Lond.). 366:69-72.
24. Tisch, R., X.-D. Yang, S.M. Singer, R.S. Libiau, L. Fugger, and H.O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature (Lond.). 366:72-75.
25. Llorente, L., Y. Richaud-Patin, R. Fior, J. Alcocer-Varela, J. Wijdenes, B.M. Fourrier, P. Galanaud, and D. Emilie. 1994. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. Arthritis Rheum. 37:1647-1655.
26. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin-10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205-1208.
27. Jacob, C.O., S. Aiso, S.A. Michie, H.O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1. Pror. Natl. Acad. Sci. USA. 87:968-972.
28. Satoh, J., H. Seino, T. Abo, S. Tanaka, S. Shitani, S. Ohta, K. Tamura, T. Sawai, T. Nobunaga, T. Oteki et al. 1989. Recombinant human tumor necrosis factor a suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84: 1345-1348.
29. Mamula, M.J., and C.A. Janeway. 1993. Do B cells drive the diversification of immune responses? Immunol. Today. 14:151-152.
30. Heath, W.R., J. Allison, M.W. Hoffmann, G. Schonrich, G. Hammerling, B. Arnold, and J.F.A.P. Miller. 1992. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature (Lond.). 359:547-549.
31. Saruhan-Direskeneli, G., F. Weber, E. Meinl, M. Pette, G. Giegerich, A. Hinkkanen, J.T. Epplen, R. Hohlfeld, and H. Wekerle. 1993. Human T cell autoimmunity against myelin basic protein:CD4+ cells recognizing epitopes of the T cell receptor b chain from a myelin basic protein-specific T cell clone. Eur. J. Immunol. 23:530-536.
32. Forsgren, S., A. Andersson, V. Hillorn, A. Soderstrom, and D. Holmberg. 1991. Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand. J. Immunol. 34:445-451.
33. Lehmann, P.V., T. Forsthuber, A. Miller, and E.E. Servart. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature (Lond.). 358:155-157.